| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of FLT3 and JAK2 (V617F) mutations in Langerhans cell histiocytosis
|
Abedalthagafi, Malak
|
|
2009
|
33 |
9 |
p. e173-e174
nvt p.
|
artikel
|
| 2 |
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia
|
Hatzimichael, Eleftheria
|
|
2009
|
33 |
9 |
p. 1272-1275
4 p.
|
artikel
|
| 3 |
Absence of mutations in the tyrosine kinase and juxtamembrane domains of C-FMS gene in chronic myelomonocytic leukemia (CMML)
|
Such, Esperanza
|
|
2009
|
33 |
9 |
p. e162-e163
nvt p.
|
artikel
|
| 4 |
Acute lymphoblastic leukemia following severe congenital neutropenia or de novo ALL?
|
Valera, Elvis Terci
|
|
2009
|
33 |
9 |
p. e139-e142
nvt p.
|
artikel
|
| 5 |
A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasias
|
Kreil, Sebastian
|
|
2009
|
33 |
9 |
p. e168-e169
nvt p.
|
artikel
|
| 6 |
A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-α by stimulation via Toll-like receptors and present antigens to naïve T cells
|
Narita, Miwako
|
|
2009
|
33 |
9 |
p. 1224-1232
9 p.
|
artikel
|
| 7 |
Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes
|
Schanz, Julie
|
|
2009
|
33 |
9 |
p. 1183-1188
6 p.
|
artikel
|
| 8 |
Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene
|
Gunn, Shelly R.
|
|
2009
|
33 |
9 |
p. 1276-1281
6 p.
|
artikel
|
| 9 |
Bispecific immunotoxins
|
Frankel, Arthur E.
|
|
2009
|
33 |
9 |
p. 1173-1174
2 p.
|
artikel
|
| 10 |
Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone
|
Ding, Li
|
|
2009
|
33 |
9 |
p. e170-e172
nvt p.
|
artikel
|
| 11 |
CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia
|
Palumbo, Giuseppe A.
|
|
2009
|
33 |
9 |
p. 1212-1216
5 p.
|
artikel
|
| 12 |
CD8+ memory T cells predominate over naïve T cells in therapy-free CML patients with sustained major molecular response
|
Usuki, Kensuke
|
|
2009
|
33 |
9 |
p. e164-e165
nvt p.
|
artikel
|
| 13 |
Decitabine-induced effusions
|
Chen, Chih-Cheng
|
|
2009
|
33 |
9 |
p. e150-e151
nvt p.
|
artikel
|
| 14 |
Disease causing nature of homozygous missense, p.A523D, alteration in the perforin gene
|
Oner, Ahmet Faik
|
|
2009
|
33 |
9 |
p. e152-e153
nvt p.
|
artikel
|
| 15 |
Editorial Board
|
|
|
2009
|
33 |
9 |
p. CO2-
1 p.
|
artikel
|
| 16 |
17β-Estradiol overcomes human myeloma RPMI8226 cell suppression of growth, ALP activity, and mineralization in rat osteoblasts and improves RANKL/OPG balance in vitro
|
Li, Qiubai
|
|
2009
|
33 |
9 |
p. 1266-1271
6 p.
|
artikel
|
| 17 |
Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma
|
Seker, Mesut
|
|
2009
|
33 |
9 |
p. e154-e156
nvt p.
|
artikel
|
| 18 |
Facts and uncertainties in monitoring treatment response in chronic myeloid leukaemia
|
Clark, Richard E.
|
|
2009
|
33 |
9 |
p. 1151-1155
5 p.
|
artikel
|
| 19 |
Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy
|
Vallera, Daniel A.
|
|
2009
|
33 |
9 |
p. 1233-1242
10 p.
|
artikel
|
| 20 |
Hypolipemiant besides antileukemic effect of imatinib mesylate
|
Gologan, Radu
|
|
2009
|
33 |
9 |
p. 1285-1287
3 p.
|
artikel
|
| 21 |
Hypothesis: How do JAK2-inhibitors work in myelofibrosis
|
Mesa, Ruben
|
|
2009
|
33 |
9 |
p. 1156-1157
2 p.
|
artikel
|
| 22 |
iASPP, A potential drug target in cancer therapy
|
Gillotin, Sébastien
|
|
2009
|
33 |
9 |
p. 1175-1177
3 p.
|
artikel
|
| 23 |
Information needs of adult patients 50 or older with newly diagnosed acute myeloid leukemia
|
Yogaparan, T.
|
|
2009
|
33 |
9 |
p. 1288-1290
3 p.
|
artikel
|
| 24 |
Inhibition of all-trans retinoic acid-induced granulocytic differentiation of WEHI-3B D+ cells by forced expression of SCL (TAL1) and GATA-1
|
Ishiguro, Kimiko
|
|
2009
|
33 |
9 |
p. 1249-1254
6 p.
|
artikel
|
| 25 |
2009 ISEH Meeting announcementB&W
|
|
|
2009
|
33 |
9 |
p. I-
1 p.
|
artikel
|
| 26 |
JAK2 mutation and atypical chronic myeloid leukemia
|
Campiotti, Leonardo
|
|
2009
|
33 |
9 |
p. e166-e167
nvt p.
|
artikel
|
| 27 |
Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects
|
Corso, Alessandro
|
|
2009
|
33 |
9 |
p. e145-e149
nvt p.
|
artikel
|
| 28 |
Malignant hematopoietic cell lines: In vitro models for the study of plasmacytoid dendritic cell leukemia
|
Drexler, Hans G.
|
|
2009
|
33 |
9 |
p. 1166-1169
4 p.
|
artikel
|
| 29 |
Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer
|
Varadarajan, Ramya
|
|
2009
|
33 |
9 |
p. 1208-1211
4 p.
|
artikel
|
| 30 |
Multicentric myeloid/NK sarcoma in an aleukemic patient evolved in refractory acute leukemia
|
Scaramucci, Laura
|
|
2009
|
33 |
9 |
p. 1294-1296
3 p.
|
artikel
|
| 31 |
Myelodysplasia paranoia: Iron as the new radon
|
Steensma, David P.
|
|
2009
|
33 |
9 |
p. 1158-1163
6 p.
|
artikel
|
| 32 |
Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST
|
Pitini, Vincenzo
|
|
2009
|
33 |
9 |
p. e143-e144
nvt p.
|
artikel
|
| 33 |
Nilotinib-induced hyperbilirubinemia: Is it a negligible adverse event?
|
Kim, Min Kyoung
|
|
2009
|
33 |
9 |
p. e159-e161
nvt p.
|
artikel
|
| 34 |
Philadelphia chromosome-positive acute myeloid leukemia (Ph+AML) treated with imatinib mesylate (IM)
|
Kondo, Toshinori
|
|
2009
|
33 |
9 |
p. e137-e138
nvt p.
|
artikel
|
| 35 |
Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy
|
Balleisen, Sebastian
|
|
2009
|
33 |
9 |
p. 1189-1193
5 p.
|
artikel
|
| 36 |
Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation
|
Kaddar, T.
|
|
2009
|
33 |
9 |
p. 1217-1223
7 p.
|
artikel
|
| 37 |
Real-time consensus on relapse risk in acute promyelocytic leukemia
|
Gallagher, Robert E.
|
|
2009
|
33 |
9 |
p. 1170-1172
3 p.
|
artikel
|
| 38 |
SDF1/CXCL12 (−801GA) polymorphism is a prognostic factor after treatment initiation in Waldenstrom macroglobulinemia
|
Poulain, Stéphanie
|
|
2009
|
33 |
9 |
p. 1204-1207
4 p.
|
artikel
|
| 39 |
siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53
|
Liu, Hang
|
|
2009
|
33 |
9 |
p. 1243-1248
6 p.
|
artikel
|
| 40 |
Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations
|
Kim, Dongho
|
|
2009
|
33 |
9 |
p. 1260-1265
6 p.
|
artikel
|
| 41 |
Successful Nilotinib therapy in an imatinib-resistant chronic myeloid leukemia patient displaying an intron-derived insertion/truncation mutation in the BCR–ABL kinase domain
|
Stagno, F.
|
|
2009
|
33 |
9 |
p. e157-e158
nvt p.
|
artikel
|
| 42 |
The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis
|
Mesa, Ruben A.
|
|
2009
|
33 |
9 |
p. 1199-1203
5 p.
|
artikel
|
| 43 |
Total serum tryptase: A predictive marker for KIT mutation in acute myeloid leukemia
|
Cairoli, Roberto
|
|
2009
|
33 |
9 |
p. 1282-1284
3 p.
|
artikel
|
| 44 |
Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells
|
Boissel, Laurent
|
|
2009
|
33 |
9 |
p. 1255-1259
5 p.
|
artikel
|
| 45 |
Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients
|
Li, Lin
|
|
2009
|
33 |
9 |
p. 1194-1198
5 p.
|
artikel
|
| 46 |
Unusual myeloma relapse after thalidomide therapy: The dark side of the moon?
|
Balleari, Enrico
|
|
2009
|
33 |
9 |
p. 1164-1165
2 p.
|
artikel
|
| 47 |
Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation
|
Sekhri, Arunabh
|
|
2009
|
33 |
9 |
p. 1291-1293
3 p.
|
artikel
|
| 48 |
When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group)
|
Cassinat, Bruno
|
|
2009
|
33 |
9 |
p. 1178-1182
5 p.
|
artikel
|
Tijdschrift beschrijving